D60.0

Clinical Causes: Autoimmune reactions where the body's immune system mistakenly attacks red blood cell precursors Certain viral infections, such as parvovirus B19, which directly suppress red blood cell production Exposure to certain drugs or chemicals that can inhibit bone marrow activity Thymomas or other thymic tumors which may be associated with immune dysfunction Other autoimmune diseases, like lupus, that can be linked to PRCA

Key Symptoms: Severe fatigue or weakness due to anemia Pale skin and mucous membranes Shortness of breath, especially during exertion Rapid heartbeat or palpitations Dizziness or lightheadedness In some cases, no symptoms are noticeable in the early stages

Diagnosis Path: Diagnosis of chronic acquired PRCA involves multiple steps. Blood tests reveal a low red blood cell count, while the white blood cells and platelet counts usually remain normal. Bone marrow biopsy is essential to confirm the diagnosis, showing an absence or marked reduction of erythroblasts, the cells responsible for producing red blood cells. Additional tests might include screening for infections, autoimmune markers, and imaging studies to assess for tumors that may be related to the condition.

Treatment Protocols: Treatment options focus on stimulating red blood cell production and addressing any underlying causes. Common approaches include: - Immunosuppressive therapy with drugs such as corticosteroids to reduce immune system attacks on red blood cell precursors - Cyclosporine or other immunosuppressants in cases unresponsive to steroids - Blood transfusions to manage severe anemia in the short term - Addressing underlying infections or removing offending drugs or chemicals - Removal of thymic tumors if present In some instances, therapies like monoclonal antibodies or bone marrow stimulation agents may be considered, especially if other treatments are ineffective. Regular follow-up and monitoring are crucial to assess the response to therapy and manage potential side effects.